The company’s abstract, titled “Osteoinductivity and Osteogenicity of Leading Allograft Bone Products,” analyzed the bone forming potential of the company’s two allograft products, OsteoAMP Allogeneic Morphogenetic Protein and Osteocel Plus.
The study has been submitted for an additional peer review.
More Articles on Devices:
DePuy Extends Brainlab Collaboration on Spine Instrumentation
Thompson Surgical Instruments Celebrates 50 Years, Launches New Products
K2M Launches SANTORINI Cage System for Spinal Vertebral Collapse, Damage
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
